© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
October 04, 2021
A study found similar rates of acute respiratory illness-related visits across race/ethnicity when all healthcare settings were combined, but ARI visits differed for race/ethnicity groups across ambulatory, emergency, and hospital settings.
Learn more about new test for diagnosing early Lyme disease in a Q&A with Adaptive Biotechnologies.
Self-testing for HIV is fast and easy, and test kits can be completed at a health department with the help of staff or at home and dropped off later.
October 03, 2021
As more agents expand the capability and variety of PrEP options, investigators consider what questions remain about the drug class.
Following the approval of cabotegravir-rilpivirine earlier this year, experts are looking forward to an expansion of the drug class for HIV.
The combination therapy's non-inferior efficacy to heavier TAF regimens may indicate a greater embrace of 2-drug regimens for people living with HIV.
Monica McArthur, MD, PhD, discusses why to-be-authorized COVID-19 vaccine doses for children may not be tiered for patient risk as they were for adults.
October 02, 2021
New late-breaking data illuminate the specific efficacy of the combination monoclonal antibodies.
The findings have supported the launch of a phase 3 trial called EVERGREEN, which is now underway.
A conversation in consideration of the high-risk psychosocial comorbidities the aging HIV population may face through COVID-19.
Oral Sabizabulin Reduces COVID-19 Deaths in High-Risk Adults
Pneumonic Plague in an Era of COVID-19
FDA: Pharmacists Can Prescribe Paxlovid to Eligible Patients
Utilizing Global Surveillance to Develop a Syphilis Vaccine